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Abstract: The misuse and overuse of antibiotics have resulted in an alarmingly high prevalence of
antimicrobial resistance (AMR) in human and animal bacteria. European monitoring programmes
show that AMR occurrence in food animals is lower in Sweden than in most other EU Member States
and that the use of antibiotics for animals is among the lowest in Europe. In this retrospective country
case study, we analysed published documents to identify factors contributing to this favourable
situation. A fundamental factor identified was early insight into and sustained awareness of the
risks of AMR and the need for the prudent use of antibiotics. Early and continuous access to data
on antibiotic use and AMR made it possible to focus activities on areas of concern. Another factor
identified was the long-term control and eradication of infectious animal diseases, including coordi-
nated activities against endemic diseases, which reduced the need to use antibiotics. Structures and
strategies for that purpose established at the national level have since proven useful in counteracting
AMR as an integral part of disease prevention and control, guided by a “prevention is better than
cure” approach. A third factor identified was consensus among stakeholders on the need to address
AMR and their cooperation in the design and implementation of measures.
Keywords: veterinary medicine; food animal production; antimicrobial resistance; antimicrobial use;
disease prevention; disease eradication; antimicrobial growth promoters; organised health control;
policies and guidelines
1. Introduction
The misuse and overuse of antibiotics have accelerated the development and emer-
gence of antibiotic resistance (AMR) and resulted in an alarmingly high prevalence of AMR
in human and animal bacteria [1]. To avert a crisis, in 2015, the World Health Organiza-
tion (WHO) adopted a Global Action Plan on AMR to reduce the incidence of infections
through disease prevention measures and to optimise the use of antibiotics in humans
and animals [1]. Resistant bacteria circulating in animal populations threaten both animal
and human health, so multi-sector collaboration between relevant sectors is required, as
reflected by the tripartite collaboration on AMR agreed in the Global Action Plan by the
Food and Agriculture Organisation (FAO), World Organisation for Animal Health (OIE)
and WHO [2].
Recognition of the risks associated with the use of antibiotics in food animals, in
particular, the use of antibiotics for growth promotion (AGP), began to emerge in the
1960s [3]. Some 30 years later, the global focus turned to AMR in food animals [4]. In 1997,
the WHO recommended banning the use of AGPs [5] and formulated global principles
for the containment of AMR, including the monitoring of AMR and antibiotic usage [6,7].
Shortly thereafter, the European Union (EU) decided to phase out the use of AGPs by
2006 [8] and initiated the monitoring of AMR in bacteria from animals in 2003 [9] and of
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antibiotic sales for animals in 2010 [10]. These monitoring programmes have shown that
the use of antibiotics in animals is lower in Sweden than in other EU Member States [11]
and that the occurrence of AMR in Sweden is among the lowest in Europe [12].
As postulated in the EU One Health Action Plan against AMR [13], lessons learnt from
successful strategies in individual Member States could be valuable for other countries and
support the objectives of the WHO action plan [1]; the aim of this paper was to identify
those key factors that have contributed to the current favourable situation in Sweden.
2. Food Animal Production
Over recent decades, animal production has undergone a dramatic change in terms
of mechanization, automation and management along with improvements of the animal
genetic capacity and feed efficiency. This has resulted in a decrease in the number of farms
producing food animals along with an increase in herd size, as summarized here for the
three major production sectors in Sweden.
In dairy production, the number of farms in Sweden producing food animals has
decreased, while the herd size on the remaining farms has increased. For example, the
number of dairy herds has decreased by around 99% during the past 70 years, from
approximately 307,000 in 1951 to 3477 in 2018 (Figure 1).
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Swedish Board of Agriculture [14]. The data for 1951–1978 include all types of cattle herds, but the
majority of farms in that period can be assumed to have had milking cows, i.e., to have been dairy
herds.
During the same period, the number of dairy cattle decreased by about 80% (1,564,000 in
1951 to 319,387 in 2018), but due to a higher yield per cow, Swedish milk production has
only decreased by about 31% [14]. During the past 40 years, the average milk yield per cow
per year has increased from about 5000 to 8900 L [15], and dairy production in Sweden is
currently among the top performers in Europe [16]. The average herd size increased from
about 14.1 cows per herd in 1979 to 91.9 in 2018 (Figure 2).
The most recent change towards larger dairy herds has occurred in herds with
>199 cows, which are increasing in number, whereas the number of herds with fewer
than 99 cows is decreasing. (Figure 3).
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Summary f Key Factors
Food ani al production in Sweden has undergone structural changes, with the concen-
tration of production in larger units and high productivity from an international perspective.
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3. Prevention and Control of Infectious Diseases
3.1. Diseases Controlled by National Authorities
3.1.1. Major Epizootic Diseases
During the 18th–20th centuries, Sweden frequently experienced outbreaks of major
epizootic diseases, which in general, were effectively controlled by national authorities [20].
In addition to the major outbreaks listed in Table 1 and outbreaks of rinderpest, conta-
gious bovine pleuropneumonia, rabies and anthrax, Swedish authorities were early in
legally defining other disease outbreaks as epizootic and accordingly controlled them
in the same powerful way, aiming for disease freedom. These diseases included bovine
genital campylobacteriosis, fowl typhoid and pullorum disease (Salmonella Gallinarum and
S. Pullorum) [20].
Table 1. Significant outbreaks of major epizootic diseases in Sweden for 1900–2020. Adapted from Cerenius [20], National
Veterinary Institute (SVA) [21] and [22].
Year Disease Animal Species Comments
1924–27 Foot and mouth disease (FMD) Cattle 11,002 herds infected.
1938–40 FMD Cattle 7293 herds infected.
1940 Classical swine fever (CSF) Pigs 230 herds infected.
1943–44 CSF Pigs 445 herds infected.
1950–56 Paratuberculosis Cattle Beef cattle, 830 animals seropositive.
1951–52 FMD Cattle 562 herds, 1 million cattle vaccinated.
1953 Salmonella epidemic Several, mainly cattle 9000 human cases, 90 deaths.
1956–57 Porcine brucellosis Pigs 76 herds infected.
1956–57 Anthrax Cattle/pigs 19 cattle herds/68 pig herds infected.
1960 FMD Cattle 6 herds infected.
1993 Paratuberculosis Cattle 53 beef cattle herds infected.
1991–97 Bovine tuberculosis Farmed deer 13 herds infected.
1995–96 Newcastle disease (ND) Poultry 650 flocks tested; 1.75 million birds/eggsdestroyed.
2007 Porcine reproductive andrespiratory syndrome (PRRS) Pigs 7 herds infected, modified stamping out.
2008–09 Bluetongue Cattle 30 outbreaks in different regions,2.7 million cattle vaccinated.
2010–20 Highly pathogenic avianinfluenza and ND Poultry 2 and 5 outbreaks, respectively.
2010–20 Anthrax Cattle 12 outbreaks.
The eradication of bovine tuberculosis (bTB) and bovine brucellosis required sub-
stantial long-term efforts. Both diseases were probably introduced by early imports of
infected breeding animals during the middle of the 19th century or earlier and became
widespread. In 1937, 30% of the cattle slaughtered in southern Sweden had macroscopic
lesions of tuberculosis [23], while in 1944, 16,000 (6%) of the cattle herds in Sweden were
infected with bovine brucellosis [24]. During the period 1897–1933, bTB was controlled by
a low-intensity and mainly unsuccessful control programme based on tuberculin tests, but
in 1934, the control was extended to a national eradication programme, and Sweden was
declared free from bTB in 1958 [25]. Efforts to eradicate bovine brucellosis were started
in 1944, based on nationwide monitoring using the Abortus Bang Ring Test, and by 1962,
the infection was eradicated [24]. As part of these eradication programmes, a nationwide
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network of veterinary laboratories was built, which facilitated the subsequent control of
other diseases (see below).
3.1.2. Salmonella
The early initiation of Salmonella control by national authorities in Sweden more
than 60 years ago is unique from an international perspective because zero tolerance for
Salmonella in the whole feed-to-food chain was applied from the start. The control of
Salmonella is therefore described in more detail here.
Animals: In 1953, S. Typhimurium spread from a domestic slaughterhouse in Sweden
and caused the death of 90 people and more than 9000 cases of illness [26]. In another
outbreak, 500 people were infected by meat imported from South America [27]. These
outbreaks of salmonellosis in humans highlighted the need to control Salmonella, which
was enforced by Swedish regulations in 1961 [28]. Thereby, findings of Salmonella from
animals, humans, feed or food were made notifiable to the authorities. Infected herds are
subject to restrictions until the infection has been eradicated, but the use of antibiotics to
clear farms of infection is not permitted [21,29].
In poultry production, the control of Salmonella is stricter, and flocks infected with
any serovar of Salmonella are destroyed. In broiler production, a voluntary control pro-
gramme run by the authorities, including the pre-slaughter testing of flocks, was initiated
in 1970 [30]. The programme became mandatory in 1984 [31]. In order to avoid possible
Salmonella contamination in broiler abattoirs, in 1991, the broiler industry introduced the
pre-slaughter testing of laying hens [20]. This was later included in a voluntary control
system in layer production, in response to the pandemic spread of S. Enteritidis in the
late 1980s [32] and became mandatory in 1994 [33]. Currently, all commercial poultry
production is under control for Salmonella [21,29].
Feed: The control of Salmonella in feed was initiated as a voluntary programme run by
the industry in 1958, when the assessment of outbreaks of anthrax from imported meat
and bone meal also frequently revealed simultaneous contamination with Salmonella [34].
The programme was later extended to the bacteriological testing of other risk ingredients
such as soy and rape meal, heat treatment of poultry feed (1972) and testing of all non-
heat-treated feed (1987), and in 1991, HACCP-based control of the whole production chain
was implemented [20]. The voluntary control became compulsory in 1993 [35], and under
current legislation, crushing plants and feed mills must be closed for decontamination
upon any detection of Salmonella on the “clean side” [36]. The control of Salmonella in feed
production, including imported feed ingredients, most certainly prevented the introduction
of this pathogen into animal production [37]. This control, and that on imported breeding
animals (see below), is considered to have prevented the introduction of S. Enteritidis into
Swedish poultry production during its pandemic spread in the late 1980s [32].
Food: Food of animal origin contaminated by any serovar of Salmonella is considered
unfit for human consumption, and in 1971, this was formalised in national legislation [38].
This zero tolerance of any contamination by Salmonella, in particular, of carcasses after
slaughter, is considered to have contributed to compliance with the pre-harvest control
of Salmonella.
3.2. Diseases Controlled by the Industry
The introduction of more intensive and specialized food animal production processes
increased health disorders caused by endemic diseases, mainly respiratory infections. Trade
in animals, especially to specialist and large-scale production units, was identified as a risk
factor. The pig industry, therefore, established a health advisory veterinary organisation
to prevent these infections as early as 1945, and provided health counselling services
(here referred to as health control) as a complement to the conventional treatment of sick
animals mainly performed by officially employed district veterinary officers [39]. The
laboratory facilities established in all regions of Sweden for the eradication of bTB and
bovine brucellosis also had sufficient capacity for providing diagnostic services for health
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control. A basic task for health control in pig production was to certify herds permitted
to sell live animals on the market, with the mandate to withdraw certification in the case
of health problems. In 1954, the Swedish dairy sector established a corresponding health
control for bovine mastitis [20], and health controls were later introduced in the beef and
sheep sectors [39]. It is estimated that today, close to 100% of all commercial dairy, pig and
poultry producers in Sweden participate in such health controls.
3.2.1. Organised Health Controls
Following an inquiry by the national veterinary services in the late 1960s [40], a parlia-
mentary decision in 1969 clarified that the industry should be financially responsible for
health controls. Prior to that decision, health controls, including the laboratory diagnostic
support described above, were subsidised by the state. However, an act on the control of
animal diseases established the concept of organised health control. The aim was to control
specific diseases and health issues of national importance, and organised health controls
were therefore eligible for state financial support. The concept was specified as follows:
“The state, through a trusting collaboration with the industry, can make the control work so that it
also benefits the state” [40]. The organised health control system initiated is managed by the
industry and led by a control organisation, usually the veterinary organisation affiliated
with the cooperative slaughterhouses or dairy associations. The organised health controls
follow rules approved by the Swedish Board of Agriculture, the supervising authority.
According to the current legislation [41], the aim of this voluntary control is to “stop or
prevent the spread of infections and diseases and to improve the health of farm animals”. All
producers can join and must be treated equally by the control organisation, for example,
regardless of whether they are linked to a cooperative or private slaughterhouse, which
commonly competes in the red meat sector. To achieve joint action by affiliated farmers,
each organised health control has a steering committee representing all key stakeholders
and the supervising authority. This structure facilitates compliance with the control and
the final eradication of a disease, for example, by preventing individual producers from
delivering animals to slaughter or milk to dairies if they refuse to follow the rules or join
the control [42].
The organised health controls have proven to be an efficient tool for preventing and
controlling diseases. A major focus was to limit risks related to the trade of animals.
Examples of infections for which organised health controls were implemented for control
or eradication are given in Table 2.
Table 2. Examples of infectious diseases eradicated (recognized free by EU) or brought under control by organised health
controls in Sweden [21,43].
Year Disease Animal Species Comment
1990–2001 Enzootic bovine leucosis (EBL) Cattle Initially, 25% of dairy herds infected. Eradicated.
1991–1996 Aujeszky’s disease (AD) Pigs Initially, 5% of sow herds infected. Eradicated.
1993–2013 Bovine viral diarrhoea (BVDV) Cattle Initially, 40% herd prevalence. Nationally declaredfreedom in 2014.
1993– Maedi-Visna (MV) Sheep Initially, 8.2% herd prevalence. Ensure disease-free herdsfor livestock trade.
1994–1998 Infectious bovine rhinotracheitis (IBR) Cattle Initially, 0.2% of dairy herds seropositive. Eradicated.
1998–2017 Paratuberculosis Cattle
Repeated introduction in beef cattle after imports; latest
case in 2005. Dairy herds never infected. Surveillance to
document a very low prevalence or possibly declare
national freedom.
1998– Porcine reproductive and respiratorysyndrome (PRRS) Pigs
One outbreak in 2007. Freedom nationally redeclared
in 2008.
1993– Campylobacter spp. Broilers Surveillance aiming at reducing prevalence.
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Hygiene and biosecurity routines on farms, in aquaculture and in feed production are
important components of disease prevention. These routines were initially implemented as
a spin-off effect from the eradication and control of specific diseases, such as bTB, bovine
brucellosis, infectious bovine rhinotracheitis and enzootic bovine leucosis in the dairy
sector; Aujeszky’s disease in the pig sector; and Salmonella in all food animal and feed
production. These measures have, for example, eliminated the need for vaccination against
the most commonly occurring viral infections in broiler production [44].
Implementing new scientific achievements and surveillance procedures has, in several
cases, been essential for the introduction of organised health controls and eradication
programmes. For example, the eradication of enzootic bovine leucosis (EBL) was facilitated
by the introduction of a bulk milk test method [45], which to date, has been applied for
several other viral infections and also parasitic diseases [46], and the use of the DIVA
vaccine, which allows for the immunological differentiation of infected from vaccinated
animals, facilitated the eradication of Aujeszky’s disease (AD) [47].
3.2.2. Organised Health Services
In addition to the organised health controls described above, the industry continues
to provide health counselling services, hereafter referred to as organised health services,
which are fully financed by the industry. In the respective production sectors, both activities
are carried out in an integrated way by the same veterinary organisations. The organised
health services focus on infections and health disorders not covered by the organised
health controls. They include annual visits to affiliated producers/farms by specialist
veterinarians and visits upon call for actions to control herd health problems. In pig
production, major improvements in health status have been achieved for traditionally
dominant infections such as atrophic rhinitis [21], E. coli-related piglet diarrhoea [48] and
swine dysentery [49], which have been eliminated as major problems. The same applies
to Salmonella in all food animals, due to the zero-tolerance policy described above [21].
Considerable improvements in health status have also been achieved in the dairy sector [50]
and the poultry sector [44,51].
The organised health services are also tasked with supporting the official surveillance
of different infectious diseases [21] and other animal health projects, including on AMR, as
described in annual reports to the Swedish Board of Agriculture [52].
3.2.3. Limitation and Control of Import of and Trade in Live Animals
The import of live animals to Sweden was identified at an early stage as a risk factor for
outbreaks of major epizootic diseases and other infectious diseases, and an early national
policy for the food animal sector was, therefore, to limit the import of live animals [20].
This strategy was challenged when Sweden joined the EU in 1995. To minimise the risk of
introducing diseases not covered by the harmonised rules for trade in cattle, pigs, sheep
and their genes (semen and embryos) within the EU, the voluntary Swedish Farmers
Disease Control Programme (SDS) was introduced by the industry in 1995 [53]. During
recent years, the measures have been extended to prevent the introduction of methicillin-
resistant Staphylococcus aureus (MRSA) in pig production [53]. Over more than 20 years of
this control system, low-volume and high-biosecurity trade in live animals from abroad
has been maintained [53]. In addition to SDS, corresponding voluntary measures by the
Swedish Poultry Meat Association (SPMA) have been in place in the poultry sector since
Sweden’s accession to the EU.
The restricted import policy prevented the introduction of porcine reproductive and
respiratory syndrome (PRRS) in pigs during its global spread in the late 1980s [54]. Like-
wise, the restricted and controlled trade in live pigs from abroad most likely mitigated
the introduction of MRSA into pig production in Sweden [55]. In addition, the pre-import
testing of day-old grandparent chickens in the late 1980s prevented the pandemic spread
of S. Enteritidis from entering the Swedish poultry population, and has also considerably
decreased the risk for the introduction of other serovars of Salmonella [32]. Voluntary
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efforts by SPMA, in cooperation with the National Veterinary Institute (SVA), have also
mitigated the introduction of Escherichia coli resistant to extended-spectrum cephalosporins
(ESC) in broiler production via breeding animals traded from abroad [56,57].
3.3. Summary of Key Factors
State veterinary leadership, veterinary infrastructure and regional veterinary labo-
ratory capacity were established early in Sweden for the eradication of major epizootic
diseases. These later became valuable tools in the prevention of other infectious diseases
and facilitated the introduction in 1945 of industry-led health counselling services. The
regulatory implementation of organised health controls in 1969 clarified the responsibility
of the industry for disease prevention but also offered a tool for financial support from
government for the control of specific diseases and other activities of national interest. This
transformed the industry-led health counselling services into coordinated and focused
activities. As a result, important endemic diseases were controlled or eradicated through
joint action by government and the industry.
Access to veterinary expertise and regular visits by veterinarians to farms enrolled
in organised health controls and organised health services provide farmers with farm-
specific advice on the management and prevention of diseases and are also important for
compliance with policies and recommendations on biosecurity, the use of antibiotics and
good agricultural practice.
The limited and controlled import and trade in animals, genes and feed ingredients
has prevented the introduction of several infectious diseases.
Hygiene and biosecurity routines on farms and in feed production were implemented
early in Sweden through the control and eradication programmes.
Although not specifically described here, or found to be specifically documented,
stringent animal welfare regulations are also considered to have improved animal health
and decreased the need for antibiotic treatment [58]. For example, limiting the stocking
density in broiler and pig production [59], weaning after 26 days of age [60], prohibiting
tail docking [61] and encouraging the use of straw bedding [61,62] in pig production are
considered to have promoted health. These measures are supported by opinions from the
European Food Safety Authority (EFSA) on the welfare of pigs [63,64].
4. Antibiotic Use and Resistance
4.1. Early and Continuous Awareness of the Problems with AMR
The concept of AMR and the need for the prudent use of antibiotics in animals
were already familiar to Swedish veterinarians in the 1950s. Numerous articles in the
national veterinary journal highlighted the issue and the risk of overuse [65–70]. In 1963, a
session at the annual Swedish Veterinary Conference was dedicated to antibiotic use and
AMR, with a Danish keynote speaker lecturing on the pros and cons of antibiotic use in
animals [71]. In subsequent years, the issue was raised again in the national veterinary
journal [72–75] and also in the trade journals [76–80]. At the annual Swedish Veterinary
Conference in 1973, there was a public debate on the use of antibiotics in animals [81].
In that year, a Swedish study by Jonsson and Jacobsson [82] questioned the practice
of providing in-feed medication to calves, and others presented AMR from a human
healthcare perspective [83,84].
From the 1950s onwards, data on AMR in animal pathogens were widely presented
(see below), making Swedish practitioners aware of AMR as a problem that could be
encountered in everyday clinical practice (e.g., [85–89]). Further emphasis was placed
on AMR as a concrete clinical problem following the documentation in the mid-1970s
of transmissible resistance in E. coli from calves and pigs in Sweden [90,91]. Additional
support for the discussion was provided by the first presentation of data on annual sales of
antibiotics for animals (see below).
In the early antibiotic era, pharmacokinetic data on antibiotics were scarce and dosages
were generally not based on hard scientific evidence. To improve the treatment of bovine
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mastitis, the distribution of penicillin to the udder was studied in Sweden as early as
the 1950s [92]. Later, pharmacokinetic studies of several other antibiotics were per-
formed [93–98]. Several of these studies questioned the dosing regimens applied, an
issue specifically highlighted in a symposium held in 1981 [99–102]. In addition, thera-
peutic studies were performed as a basis for antibiotic treatment [103–113]. Since 1973,
harmonised information (Fass Vet) on the characteristics, indications and dosages of phar-
maceutical products, including antibiotics, licensed for use in animals has been compiled
by the Swedish Association of the Pharmaceutical Industry (www.lif.se). Fass Vet is up-
dated annually and distributed to all veterinarians in Sweden, electronically since 2017
(www.fass.se). The contents are approved by the competent authority (currently the
Swedish Medicinal Products Agency).
4.2. Ban on AGPs
As a result of the national focus on the use of antibiotics and AMR described above,
Sweden became the first country in the world to legislate on the withdrawal of antibiotics
for growth promotion, and the use of AGPs was banned in 1986. At that time, AGPs were
included in practically all feed for pigs and broilers in Sweden. The ban was preceded by
an intensive debate in the media and the industry, and by scientific evaluations by national
authorities and other stakeholders, as reviewed by Nordéus [114]. It was argued, for
example, that society/consumers preferred animal production not to be dependent on the
routine use of antibiotics. In response to this, the Federation of Swedish Farmers voluntarily
issued a policy on the restrictive use of antibiotics in 1981 [114,115] and requested a total
ban on AGPs in 1984, following which the total national ban on AGPs came into force in
1986 [114]. The implementation and consequences of the ban on AGPs and on the sales
of antibiotics were reviewed by Wierup [116]. The ban also led to an increased focus on
disease prevention by means other than the use of antibiotics [117].
When Sweden joined the EU in 1995, the national ban on AGPs was challenged,
and Sweden was asked by the EU to provide scientific evidence for upholding the ban.
To obtain relevant evidence, a thorough review of the pros and cons of AGP use was
made [118]. The evidence provided and the recommendation by the EU Scientific Steering
Committee to phase out the use of AGPs [119], combined with a lobbying effort from
Swedish representatives to uphold the ban, was probably an important contributing factor
in the subsequent complete ban on AGPs in the EU in 2006 [120].
4.3. Prevention and Control of Bacteria with Specific Resistance
Efforts have also been made to directly counteract the spread of bacteria with AMR
of specific importance. For example, in 1995, a policy on the treatment of mastitis in
dairy cows recommended that cows infected with penicillin-resistant Staphylococcus aureus
should be culled instead of treated [121]. The reduction in the occurrence of penicillin-
resistant S. aureus from 10% in 1985 [122] to about 1% in recent years [123] is probably
largely an effect of adherence to this recommendation. In another example, an outbreak of
tiamulin-resistant Brachyspira hyodysenteriae in pig herds in 2016 was actively curbed [124].
This organism causes swine dysentery in pigs, and tiamulin is vital for treatment in affected
herds. Efforts to control the spread of E. coli resistant to ESC in broiler production and
MRSA in pig production by the control of imported animals are other examples of work to
contain specific types of resistance.
Legislative efforts are also in place to mitigate the spread of bacteria with specific
resistance, with the detection of methicillin-resistant coagulase-positive Staphylococci (MRS)
and carbapenemase-producing Enterobacteriaceae (CPE) in animals being made notifiable
in 2008 and 2012, respectively [125]. Complementary legislation in 2013 [126] defined the
management of MRS cases in cats, dogs and horses and made provisions for infection
prevention control plans in veterinary practices. The legislation was accompanied by
recommendations from the Swedish Veterinary Association (SVF) [127]. The impact of
Antibiotics 2021, 10, 129 10 of 24
these measures is evident in the fact that CPE has not been detected in animals in Sweden
and that the situation regarding MRS is favourable [128].
4.4. Access to Data on Use of Antibiotics
Data on veterinary sales of antibiotics for animals in Sweden have been compiled and
analysed by the SVA since 1980 [129–134]. Earlier data from the human sector made it
possible to compare patterns of antibiotic use in animals and humans [135]. Initially, the
data were based on sales of antibiotics for animals from wholesalers to pharmacies, but
from 2003, they were based on sales from pharmacies to animal owners (prescriptions) or to
veterinarians (requisitions). Specific data on antibiotic use at the farm level are not available,
and the identification of sales to specific animal species is limited but can be obtained by
combining sales data and data from other sources, as outlined by Grundin et al. [136].
As of 2000, sales data have been reported and analysed by the SVA in the yearly reports
from the resistance monitoring programme Svarm (see below). Since 2002, they have been
released together with the corresponding data from the human sector (www.sva.se). In
addition, sales data have been reported annually to the European monitoring system on
antibiotic sales for animals since the start of the programme [10] and to the OIE since 2016
(OIE [137]).
Sales information is regularly communicated at conferences and meetings and also
attracts general public interest. It is also used in the formulation of national guidelines
on the use of antibiotics and in assessments of compliance with recommendations and
regulations on the use and prescription of antibiotics.
4.5. Access to Data on Antibiotic Resistance
Data on AMR in animal bacteria have been compiled and presented since the
1950s. Initially, the data originated from prevalence studies and research projects
(e.g., [85,86,88,90,138–141]. However, since 1978, resistance in Salmonella spp. from ani-
mals has been monitored yearly at the SVA and in 2000, this activity was extended to the
Svarm programme, following a government decision. In Svarm, resistance in salmonella,
campylobacter, indicator bacteria from healthy animals and several animal pathogens is
monitored, and the data are presented and analysed in yearly reports. Since 2012, data
from Svarm have been presented with corresponding data from the human sector compiled
by the Public Health Agency of Sweden in an integrated report (Swedres-Svarm) available
online (www.sva.se).
Data on AMR from a clinical perspective are also regularly communicated to veteri-
narians at conferences and meetings, in general, highlighting the risks of the misuse and
overuse of antibiotics. The data are also used in the elaboration of national guidelines on
the use of antibiotics and for evaluating the effects of measures to mitigate resistance, for
example, containing the spread of E. coli resistant to ESC in broiler production [57].
4.6. Policies, Guidelines, Recommendations and Legislation
Following the ban on AGPs, in 1990, the SVF issued guidelines on the use of antibiotics
for the group treatment of pigs [142], and in 1999, it issued a general policy on the use
of antibiotics in animals [143]. A policy on the treatment of mastitis in dairy cows was
launched by independent experts in 1995 [121]. Later, the SVF gathered practitioners
and experts on specific animal species and experts in the field of antibiotics to produce
specific guidelines for companion animals, cattle, pigs, horses, sheep and goats. Those
documents aim to balance the need for effective therapy with the need to minimise the
emergence of AMR, for example, by advocating the use of narrow-spectrum antibiotics and
avoidance of substances such as fluoroquinolones and third-generation cephalosporins,
which are among the antibiotics of the highest priority of those categorised by the WHO as
critically important in human healthcare [144]. The SVF guidelines are revised regularly
and available on the website of the organisation (www.svf.se). To complement those
policies and guidelines, since 201,2 the Swedish Medical Products Agency has issued
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detailed recommendations on the treatment of specific diseases in various animal species,
which are available on the website of the agency (www.lakemedelsverket.se).
Basic elements in the legislation since the 1950s on medicinal products for animals
are that antibiotics may only be used in animals after prescription and that veterinarians
may not sell antibiotics for profit [145]. Antibiotics may be prescribed to farm personnel for
specified clinical conditions in farm animals without the prior examination of an animal
by a veterinarian. This so-called “conditional use” is strictly regulated in legislation [146]
and includes training courses for farmers and regular visits by the prescribing veterinarian.
Since 2014, antibiotics of special importance in human healthcare, for example, glycopep-
tides, carbapenems and ceftaroline, are restricted from use in animals [146]. The use of
fluoroquinolones and third-generation cephalosporins is limited by legislation to situations
where laboratory tests show a lack of alternatives. To prevent the spread of contagious
diseases at clinics and ambulatory practices, the legislation requires veterinary practition-
ers to have infection prevention and control plans [126]. These plans must also aim to
mitigate the spread of resistant bacteria, for example, methicillin-resistant Staphylococcus
pseudintermedius (MRSP), in animal healthcare.
4.7. Summary of Key Factors
Since the mid-1950s, shortly after antibiotics became available for use in animals in
Sweden, prudent use and the risks of AMR developing have frequently been discussed
within the veterinary profession (practitioners and researchers). Antibiotics are considered
important tools for the treatment of bacterial infections that need to be protected, not
miracle drugs for dramatically improving animal production.
Data on the occurrence of AMR have been collected and disseminated in Sweden since
an early stage and show the magnitude of the present and future risks for the veterinary
and human sectors. Data on antibiotic sales, regularly reported since 1980, make it possible
to assess compliance with legislation and policies. Access to data on AMR and on sales of
antibiotics make it possible to devise policies, recommendations, guidelines and legislation,
and also to evaluate the effect of actions taken. This has transformed general awareness of
AMR into concrete knowledge on prudent use and into concrete actions to mitigate the
emergence and spread of AMR.
The ban on AGPs in 1986 decreased the sales of antibiotics substantially and put the
focus on disease prevention by other means, including measures for improved animal
management, feeding and housing. The discussions leading to the ban involved different
actors, including farmers’ cooperatives, veterinarians, politicians and relevant authorities,
with consumer confidence as an important argument. This made AMR, the use of antibiotics
and sustainable animal production important issues on the political agenda, which is still
the case [147].
5. Cooperation in Problem Solving
5.1. Control of Infectious Diseases
In the control of infectious diseases, there is generally constructive cooperation be-
tween authorities, industry and academia/veterinary expertise in Sweden. The major
stakeholders are the government; the competent authorities; veterinary and other aca-
demics; industry, representing farmers, slaughterhouses and dairies; and also animal
breeding and animal feed companies. The Federation of Swedish Farmers acts as a link
between the government and industry. Examples of formal cooperation are the steering
committees for the organised health controls, which cooperate with national authorities
and industry. However, “ad hoc groups” have also been formed for other animal health,
food safety and public health issues, such as Campylobacter, Salmonella and enterohemor-
rhagic Escherichia coli (EHEC), and for managing the use of zinc oxide in pig production.
A large programme introduced in 2016, with funding from the Swedish Board of Agri-
culture, focuses on biosecurity on individual holdings, aiming at reducing the spread of
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infectious diseases [148]. The programme is run by the industry-owned animal health
service providers.
For the control of endemic diseases, including associated interventions on individual
animal holdings, the industry-led veterinary organisations, and experts from academia
and from the SVA are the most significant players. Clinical practitioners also play an
important role and, together with farmers, are the first to observe and highlight animal
health problems, including those related to AMR. Major animal health-related control
measures are initially devised by academia, the SVA or industry, and formally elaborated
and developed further at meetings chaired by the competent authority.
A One Health perspective has been used to address zoonotic infectious diseases since
the Zoonosis Council, including representatives from the human sector, was established as
a national collaborative forum for authorities and organisations in 1997 [149]. At council
meetings, strategies in the zoonosis area are elaborated and discussed, to achieve mutual
understanding between all the authorities and organisations involved.
5.2. Counteracting AMR
There is also cooperation between stakeholders on specifically addressing AMR, in a
way similar to that described for infectious diseases above. For example, since 2005, the
SVA and Farm and Animal Health, the industry-owned animal health services provider,
have cooperated on monitoring AMR in food animals within the SvarmPat project [128].
Likewise, the SVA cooperates with the SPMA on issues related to AMR in broiler produc-
tion, for example, on reducing the occurrence of ESBL [128]. Moreover, recommendations
and guidelines on the use of antibiotics and measures to mitigate the spread of AMR are
elaborated with the participation of experts from several sectors (see above). In 2008, the
network Strama VL was started as a platform for enabling stakeholders in the veterinary
sector to exchange information, analyse problems, pinpoint solutions and initiate priori-
tised activities. A secretariat at the SVA coordinates the network and acts as a contact point
and a centre of knowledge [150].
A One Health perspective on AMR has been successively introduced by increased
cooperation between the veterinary and human sectors. Thus, when the Swedish strategic
programme against antibiotic resistance (Strama) was formed in 1995 to counteract AMR in
the human sector, the veterinary sector was involved in the network [151]. The cooperation
against AMR between sectors was eventually formalised in 2012 by the creation of the Inter-
sectoral Coordinating Mechanism (ICM) chaired by the Public Health Agency of Sweden
and the Swedish Board of Agriculture [152]. The ICM brings together representatives from
about 20 national authorities and organisations across many sectors: human and animal
health, food production, the environment, research, trade and international relations. In the
early 2000s, the National Board of Health and Welfare, in cooperation with stakeholders
from several sectors, elaborated a proposal for a national strategy on AMR, which was
presented to the Swedish Parliament in 2005 [153]. Moreover, under the auspices of the
ICM, action plans on AMR for authorities were presented in 2015 [154] and revised in
2017 [155]. Other examples of cooperation are the presentation and analysis of data on
antibiotic sales and AMR by the National Veterinary Institute and the Public Health Agency
of Sweden in yearly Swedres-Svarm reports (see above) and various research activities, for
example, the IMPACT project [156].
5.3. Agricultural Policy with Incentives for Livestock Production
Until the early 1990s, Swedish agricultural policy included incentives for livestock
production. Apart from broiler production and some minor sectors, domestic food pro-
duction was supported by a differentiated system of price regulation and other budget
measures. This facilitated government support of the animal health sector until Sweden’s
accession to the EU in 1995. Before then, the Federation of Swedish Farmers held regular
formal meetings and negotiations with the government, which included discussions on
investments in the animal health sector. This pattern of cooperation has been maintained,
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although economic accountability has been modified, and economic support from the
government has generally decreased substantially in recent years.
The costs for the control and eradication of the major epizootic diseases (Table 1) have,
to date, been covered by the Swedish government. In the case of salmonella, farmers’ costs
for eradication were fully covered until 1984, when the compensation was reduced for
cattle and pig farms and withdrawn for broiler production [20]. Today, compensation is
higher for herds affiliated with organised health controls focusing on biosecurity.
Government support facilitated the creation of the industry-led health counselling
veterinary organisations for the prevention of endemic infection. In 1969, the industry
became financially responsible for that activity, but up to Sweden’s EU accession in 1995,
the government continued to provide financial support for the control and eradication
of specific diseases through organised health controls (see above, Table 2). That financial
support was used to create economic incentives for producers to join control programmes.
In addition, animal health insurance companies require farms to have disease prevention
measures in place, for example, an affiliation with an organised health control, to qualify for
compensation for outbreaks of a disease. Today, the financial support from government is
mainly limited to funding the control organisations to perform specific activities considered
of national importance, for example, disease surveillance. In addition, since 1934, the
government has provided financial support to the district veterinary organisations to ensure
that clinical animal health services are available to farmers in the whole of Sweden [20].
5.4. Summary of Key Factors
Using regulatory and financial tools, the competent authority in Sweden has facilitated
active control solutions for infectious diseases and AMR.
Cooperation between relevant stakeholders has enabled mutual understanding of and
consensus on the need for and benefits of implementing measures to prevent and control
infectious diseases and to counteract AMR.
Cooperation between national authorities in the human and animal sectors from a
One Health perspective has strengthened the basis for strategies against zoonotic diseases
and AMR in the animal sector. Research cooperation between the two sectors has further
increased consensus.
6. Discussion
In Sweden, sales of antibiotics for use in animals and the prevalence of AMR in food
animals are low in comparison with those in other EU Member States [11,12]. Moreover,
in 2019, more than 90% of the overall sales of antibiotics for use in animals consisted of
products for the treatment of individual animals, 58% of which were narrow-spectrum
benzylpenicillin [128]. These data indicate a limited need for antibiotic therapy and
adherence to the principles of prudent use set out by the European Medicines Agency
(EMA) [157]. This case study shows that the favourable situation in Sweden is the result of
several factors.
6.1. Early Awareness
A factor of basic importance is probably the early and now-widespread awareness
among veterinarians and farmers of the risks of AMR and the need for the prudent use of
antibiotics. This is likely due to the discussions on antibiotic use in animals starting early in
Sweden, in the 1950s. These discussions were supported by access to data on antibiotic use
after 1980 and early detailed national reports on the occurrence of AMR in bacteria from
animals. The Swedish ban on AGPs in 1986, the first in the world, was actually requested
by farmers, which exemplifies the general awareness of AMR even at that time. The request
for a ban was probably also a response to the ongoing public debate on the state of animal
husbandry that started in the mid-1970s and threatened to undermine consumer trust in
Swedish food animal production [114,115].
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6.2. Cooperation in Prevention and Control of Infectious Diseases
A major reason for the low current use of antibiotics is that the need for antibiotic
therapy has been reduced by successful long-term efforts to prevent and control infectious
diseases and to eradicate these diseases when possible. These efforts started in the pre-
antibiotic era and demonstrate a committed attitude to the prevention of infectious diseases.
In outbreak situations, substantial efforts are made to trace and eliminate the source of
infection, making it possible for Sweden to achieve disease-free status even for diseases
such as bovine paratuberculosis [21,158] and effectively control and eliminate Salmonella
from infected herds and feed mills [21]. An even more important factor in reducing the
need for antibiotics is that similar strategies are applied for endemic diseases, applying a
concept of “prevention is better than cure”, as discussed below.
A significant factor for the achievements in animal health in Sweden is the longstand-
ing cooperation between relevant stakeholders. This enables mutual understanding of
and consensus on the need for and benefits of controlling diseases, even among stake-
holders with different economic priorities, usually at meetings with a national perspective
chaired by the competent authority with its regulatory and economic power, including
both a “carrot and stick”. For example, active participation by farmers’ organisations has
been identified as a strong factor in the control of bovine viral diarrhoea (BVDV) [159].
Consensus was reached as early as the 1950s on regulations treating animal feed as a po-
tential source of infection, i.e., a “feed to fork” perspective, in contrast to the “farm to fork”
perspective still applied in the EU [160]. Measures to mitigate AMR have been decided in
line with the so-called “Swedish model”, also accounting for consumer opinion [16,136].
Cooperation and consensus between stakeholders has also been identified as a key factor
in the success of work against AMR in Danish pig production [161].
6.3. Organised Health Controls for Prevention of Endemic Diseases
The introduction of organised health controls in 1969 was strategically important,
because it opened the door for indirect government leadership in the control of endemic
diseases, in cooperation with industry and its veterinary organisations. In other countries,
government and regulatory influence in the prevention and control of endemic diseases
is often lacking, although these diseases cause the highest burden in animal production
and are the major targets for antibiotic treatments [162]. Furthermore, Sweden considers
the control and eradication of viral diseases, which predispose for bacterial infections that
require antibiotic treatment (e.g., BVDV, EBL, MV, PRRS, AD, Caprine arthritis encephalitis
and infectious bursal disease) to have health-supporting effects beyond their direct clinical
impact [117,163]. In addition to the eradication of several infections (Table 2), the organised
health controls cooperate in the surveillance of infectious diseases and were, for example,
early in identifying the introduction of PRRS in 2007, allowing it to be successfully eradi-
cated [164,165]. In cases of health problems on individual farms, the ambition is to identify
and eliminate the basic problem, i.e., “problem solving at the root”, instead of alleviating
clinical problems by using antibiotics.
The long-term disease preventive measures taken in collaboration between govern-
ment agencies and other stakeholders have improved animal health and decreased the
need for the use of antibiotics. The best example of this is probably Swedish commercial
broilers, with a yearly production of about 100 million chickens, where only 0.25% of flocks
(8 of 3178) were treated with antibiotics in 2018 [166].
6.4. Financial Incentives
The national incentives for livestock producers, initially introduced in Sweden to en-
sure national food security in the event of war and to facilitate the structural rationalisation
of the farm industry, limited the cost to individual farmers of joining disease control pro-
grammes until Sweden’s entry into the EU in 1995. In addition, the price regulation system
during that period and limited imports of animal-derived food products minimised the
risk of producers losing market share due to the costs of disease control. This facilitated the
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implementation of costly eradication programmes, which were funded on a national basis
owing to strong arguments, primarily from veterinarians and industry. This situation may
reflect a Swedish attitude to respecting facts and trust among farmers in politicians and
relevant animal health authorities, including the industry’s own veterinary organisations.
Although the control and eradication of diseases in farm animals may seem to be associated
with high costs, the actual burden of disease justifies the costs of measures for disease
control and hygiene [167]. This is exemplified by the eradication of AD in pigs [168], BVDV
in cattle [169] and swine dysentery in pigs [170]. Additionally, when avoided costs for
human illness are considered, it has been shown that for salmonella, the benefits exceed
the costs for the control [171,172].
6.5. Access to Data on Sales of Antibiotics and AMR
Data on sales of antibiotics and the occurrence of AMR have made the discussion on
the use of antibiotics more concrete but have also formed the basis for measures and actions
and for the evaluation of actions taken. Recommendations and policies on the therapeutic
use of antibiotics and infection control procedures have been regularly updated, and
actions against resistance of specific importance, for example, MRSA, have been developed,
including legislative measures. Policies and guidelines are generally well received and
valued by Swedish veterinary practitioners [173,174] and also by Swedish farmers [175].
This approach to interventions against AMR in the face of unwanted trends and new
knowledge was highlighted by the Directorate-General for Health and Food Safety (DG-
SANTE) of the European Commission as an important factor for the favourable situation
in Sweden [176], and is in line with the action plans against AMR issued by the WHO [1]
and the European Commission [13].
6.6. Early Action
It is interesting to note that in three areas of major importance for counteracting AMR,
Sweden took control actions long before other countries [136]. The control and eradication
of several diseases, for example, Salmonella infections, bTB and brucellosis, was initiated
early. The successful control of Salmonella has been recognised internationally; for example,
in 1993, Sweden was engaged by the WHO to teach others about Salmonella control in
poultry [177]. In 1980, Sweden became the first country in the world to publish data
on the sales of antibiotics [133], and in 1986, it became the first country to ban the use
of AGPs [114]. The experiences gained in Sweden were valuable when a ban on AGPs
was introduced later in other countries, for example, the other Nordic countries [178,179].
Sweden was also comparatively early in setting up a comprehensive national monitoring
programme for AMR in animals (2000). Furthermore, Sweden was the first country in
the world (1986) to ban the use of meat and bone meal from fallen stock or sick animals
in animal feed, which apparently protected Sweden from an outbreak of C-type Bovine
spongiform encephalopathy BSE [180,181].
6.7. Geographical Location
This review did not find any evidence that the geographical location of Sweden
or differences in, for example, climate or the intensity and productivity of food animal
production could explain the favourable animal health situation and, thereby, the low use
of antibiotics. The climate in the regions of Sweden where most food animal production is
located is similar to that in northern continental Europe, and the spread of vector-borne
diseases to new regions attributed to global warming, for example, bluetongue [182]
and Schmallenberg virus [183], has also affected Sweden. Sweden, like several other
EU Member States, has a long sea border, which decreases the risk of the uncontrolled
transboundary movement of animals and animal products. However, in most countries,
outbreaks of transboundary diseases in the past were mainly caused by the regular trade
and imports of live animals, before these were properly regulated [184]. We found no
indications that the conditions for the dissemination of infectious diseases are different
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in Sweden than in other developed countries. Before effective controls were in place,
transboundary diseases introduced into Sweden (Table 1) were spread widely, often up to
the far north of the country above the polar circle.
Food animal production in Sweden has, in principle, undergone the same structural
changes as in most other developed countries. The spread of infections between and
within farms is mainly limited by the biosecurity measures applied on individual farms,
which may be more difficult to achieve in countries with denser animal populations than
Sweden. However, the size of the national food animal production sector does not appear
to be a factor explaining the favourable situation regarding AMR in Sweden [136,161]. For
example, the consequences of the withdrawal of AGPs in Danish pig production were very
similar to those observed in Sweden 20 years earlier, despite the much larger pig production
sector in Denmark [116,185]. Since the productivity in Swedish animal food production
is generally on the same level as in other developed countries, it can be concluded that
it is possible to combine high productivity in animal production with a restricted use of
antibiotics, as also found, for example, in Denmark [161]. The experiences from Sweden
are, therefore, generally applicable to other countries.
6.8. Future Challenges
A major future challenge for Sweden is to find ways to maintain the good status
achieved for animal health and AMR while not contravening harmonised EU rules on
the intracommunity movement of animals and international standards on trade in live
animals. For example, it is of vital importance for Swedish pig production to prevent the
introduction of PRRS, which, apart from causing economic losses, would be a major trigger
for the increased use of antimicrobials, as found in other countries [163]. In order to comply
with the WHO [1] and EU [13], in action plans against AMR, it is therefore necessary for
Sweden to find transparent and evidence-based procedures for preventing the introduction
or reintroduction of important infections and bacterial strains with special antimicrobial re-
sistance. The new EU Animal Health Law [186] and Veterinary Medicines Regulation [187]
provide significant incentives for individual countries and farmers to maintain or improve
their animal health status, thereby decreasing the need for antimicrobials, and to strive for
a decreased and prudent use of antimicrobials, thereby lowering the risk of the emergence
of AMR. These are all necessary steps for EU-wide and global progress in efforts to contain
AMR. Another challenge for Swedish pig production is to cope with the phasing out of
zinc oxide in the EU [188] without increasing antibiotic use. The ongoing trend towards
larger pig and dairy herds might also facilitate the spread of infectious diseases and thereby
pose a challenge for infection control. An overall challenge for Swedish producers is to
maintain ambition and economic power for animal health investments, which from a
short-term perspective, may not be rewarded on the open market. It is crucial to maintain
understanding/conviction regarding the overall benefits of healthy animals.
7. Materials and Methods
We retrieved and analysed documents published from Sweden since the early 1900s
with the aim of identifying factors and measures undertaken that are likely to have con-
tributed to the favourable situation regarding antibiotic use and AMR. The work was
structured around the three major areas: 1. the prevention and control of infectious dis-
eases; 2. antibiotic use and resistance; 3. cooperation in problem solving. The focus was on
farm animals, and as a background, data on the food animal production during the same
period were retrieved.
To retrieve scientific documents, we used PubMed searches, and to retrieve grey
literature and legislative documents, Google searches were used. In addition, all issues of
the journal of the Swedish Veterinary Association since 1945 and the programmes of the
yearly national veterinary conferences since the mid-1950s were scrutinized for articles
and other material related to antibiotics. Official inquirers related to the animal sector and
policy documents on the use of antibiotics were also consulted. In addition, we received
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valuable information and advice from specific key persons (see Acknowledgements) with
insight into the animal health sector and the work against AMR in Sweden. These key
persons also read and commented on the first draft of this manuscript.
8. Conclusions
This case study revealed that a fundamental factor in Sweden’s favourable status as
regards antibiotic sales and AMR was an early insight into and sustained awareness of the
risks of AMR and the need for prudent use to maintain the efficacy of antibiotics. Early
access to annual data on antibiotic sales and AMR provided insights and made it possible
to focus measures on areas of concern and to assess the impact of these measures.
Another major factor has been the long-term control and eradication of infectious
diseases, including endemic diseases, which reduced the need for the use of antibiotics.
The structures and strategies established for that purpose, under government leadership
and support, also proved useful for counteracting AMR as an integral part of disease
prevention and control.
A third vital factor for success has been the consensus among relevant stakeholders
on the need to address AMR and control infectious diseases, and stakeholder cooperation
in the design and implementation of relevant measures.
In summary, early awareness, longstanding efforts to prevent diseases and consensus
between stakeholders explain the success of Swedish work in preventing the development
of AMR.
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